It must be — as an essential component of the response to the antimicrobial drug resistance problem
The growing threat of antimicrobial drug resistance (AMR) is attracting the attention of national governments and international organisations. In the words of Margaret Chan, Director-General of the World Health Organization, “We are hearing one alarm bell after another.”1 This is apparent in primary care, where the frequency of antibiotic-resistant infections is increasing. The emergence of AMR is a multifaceted societal problem that requires action from a range of actors, including the pharmaceutical, agricultural and food production industries.2 But it is the health care sector, where antibiotics are prescribed and patients with resistant infections are seen, that the impact of AMR is most acute. This is especially relevant in Australia, where antibiotic consumption is among the highest of the OECD countries.3
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Chan M. WHO Director-General addresses ministerial conference on antimicrobial resistance. European Union Ministerial Conference on Antimicrobial Resistance, Amsterdam: Netherlands, 10 Feb 2016. http://www.who.int/dg/speeches/2016/antimicrobial-resistance-conference/en/ (accessed Apr 2017).
- 2. O’Neill J (chair). Tackling drug-resistant infections globally: final report and recommendations. May 2016. London: Review on Antimicrobial Resistance, 2016. https://amr-review.org/sites/default/files/160518_Final%20paper_with%20cover.pdf (accessed Apr 2017).
- 3. Organisation for Economic Co-operation and Development. Health at a glance 2015. How does Australia compare? https://www.oecd.org/australia/Health-at-a-Glance-2015-Key-Findings-AUSTRALIA.pdf (accessed Apr 2017).
- 4. Public Health England. English surveillance programme for antimicrobial utilisation and resistance (ESPAUR). Report 2016. London: PHE: 2016. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/575626/ESPAUR_Report_2016.pdf (accessed Apr 2017).
- 5. McCullough AR, Pollack AJ, Plejdrup Hansen M, et al. Antibiotics for acute respiratory infections in general practice: comparison of prescribing rates with guideline recommendations. Med J Aust 2017; 207: 65-69.
- 6. Gulliford MC, Dregan A, Moore MV, et al. Continued high rates of antibiotic prescribing to adults with respiratory tract infection: survey of 568 UK general practices. BMJ Open 2014; 4: e006245.
- 7. Gulliford M, Latinovic R, Charlton J, et al. Selective decrease in consultations and antibiotic prescribing for acute respiratory tract infections in UK primary care up to 2006. J Public Health 2009; 31: 512-520.
- 8. Ashworth M, Latinovic R, Charlton J, et al. Why has antibiotic prescribing for respiratory illness declined in primary care? A longitudinal study using the General Practice Research Database. J Public Health 2004; 26: 268-274.
- 9. Venekamp RP, Sanders S, Glasziou PP, et al. Antibiotics for acute otitis media in children. Cochrane Database Syst Rev 2013; (1): CD000219.
- 10. Spinks A, Glasziou PP, Del Mar CB. Antibiotics for sore throat. Cochrane Database Syst Rev 2013; (11): CD000023.
- 11. National Institute for Health and Care Excellence. Prescribing of antibiotics for self-limiting respiratory tract infections in adults and children in primary care (Clinical guideline CG69). July 2008. https://www.nice.org.uk/guidance/cg69/chapter/1-Guidance (accessed Apr 2017).
- 12. Little P, Gould C, Williamson I, et al. Reattendance and complications in a randomised trial of prescribing strategies for sore throat: the medicalising effect of prescribing antibiotics. BMJ 1997; 315: 350-352.
- 13. Petersen I, Johnson AM, Islam A, et al. Protective effect of antibiotics against serious complications of common respiratory tract infections: retrospective cohort study with the UK General Practice Research Database. BMJ 2007; 335: 982.
- 14. Gulliford MC, Moore MV, Little P, et al. Safety of reduced antibiotic prescribing for self limiting respiratory tract infections in primary care: cohort study using electronic health records. BMJ 2016; 354: i3410.
- 15. Spurling GK, Del Mar CB, Dooley L, et al. Delayed antibiotics for respiratory infections. Cochrane Database Syst Rev 2013; (4): CD004417.
- 16. Aabenhus R, Jensen JU, Jørgensen KJ, et al. Biomarkers as point-of-care tests to guide prescription of antibiotics in patients with acute respiratory infections in primary care. Cochrane Database Syst Rev 2014; (11): CD010130.
- 17. Hallsworth M, Chadborn T, Sallis A, et al. Provision of social norm feedback to high prescribers of antibiotics in general practice: a pragmatic national randomised controlled trial. Lancet 2016; 387: 1743-1752.
- 18. NHS England. Quality premium: guidance for 2016/17. Mar 2016. https://www.england.nhs.uk/wp-content/uploads/2016/03/qualty-prem-guid-2016-17.pdf (accessed Apr 2017).
- 19. NHS England. Success in NHS push to reduce avoidable antibiotic prescribing [media release]. 23 Mar 2016. https://www.england.nhs.uk/2016/03/antibiotic-prescribing/ (accessed Apr 2017).
No relevant disclosures.